Galenica: Update on the COVID-19 situation - Galenica will hold its Annual General Meeting without shareholder presence and is proposing a dividend payment as announced Donnerstag, 09. April 2020 - 06:54

The Galenica Group will hold its Annual General Meeting as planned on 19 May 2020, but shareholders will not be able to physically attend due to the Federal Council’s measures to combat the coronavirus. As announced, the Board of Directors will propose to shareholders a dividend of CHF 1.80 per share.

In March, pharmacies and other companies within the Group recorded extraordinarily high sales. Volumes at its logistics companies, which supply the entire healthcare market, increased massively, meaning that capacity limits in the distribution centres were substantially exceeded on certain days. Since the beginning of April, there has been a sharp decline in frequency and sales in the pharmacies and, correspondingly, in the Group’s logistics companies. Depending on its impact and duration, this extraordinary situation could have a negative impact on the 2020 result. Despite this uncertainty, Galenica is keeping its guidance for 2020, published at the beginning of March, unchanged until further notice.

The rapid increase in patients and customers in March placed extreme demands on Galenica Group employees, especially those working at the front line in pharmacies and home care, as well as in the distribution centres and in production. Operations, which ensure the supply of medicines to the Swiss population, could only be maintained thanks to the outstanding dedication of all employees. We would like to take this opportunity to thank them for their extraordinary commitment.

• Download press release

• 2019 annual results of the Galenica GroupTuesday, 10 March 2020
• Pleasing sales growth and increase of 2019 earnings guidanceTuesday, 21 January 2020
• Change at the head of the Galenica GroupThursday, 31 October 2019

Galenica Ltd.

Galenica Ltd.